Enterocyte fatty acid-binding proteins (FABPs): Different functions of liver and intestinal FABPs in the intestine

https://doi.org/10.1016/j.plefa.2014.10.001Get rights and content

Abstract

Fatty acid-binding proteins (FABP) are highly abundant cytosolic proteins that are expressed in most mammalian tissues. In the intestinal enterocyte, both liver- (LFABP; FABP1) and intestinal FABPs (IFABP; FABP2) are expressed. These proteins display high-affinity binding for long-chain fatty acids (FA) and other hydrophobic ligands; thus, they are believed to be involved with uptake and trafficking of lipids in the intestine. In vitro studies have identified differences in ligand-binding stoichiometry and specificity, and in mechanisms of FA transfer to membranes, and it has been hypothesized that LFABP and IFABP have different functions in the enterocyte. Studies directly comparing LFABP- and IFABP-null mice have revealed markedly different phenotypes, indicating that these proteins indeed have different functions in intestinal lipid metabolism and whole body energy homeostasis. In this review, we discuss the evolving knowledge of the functions of LFABP and IFABP in the intestinal enterocyte.

Section snippets

Fatty acid-binding proteins

The fatty acid-binding protein (FABP) family comprises 14–15 kD size intracellular proteins, which were discovered beginning in the 1970s [1], [2]. Presently, there are nine known FABPs that are present in high abundance (1–5%) in the cytosol of most tissues, plus the related cellular retinoid-binding proteins [3], [4]. The names for the proteins came from the tissue in which they were initially identified, but as some FABPs are expressed in multiple tissues, a numeric nomenclature is in use as

FABPs in the intestinal enterocyte

The intestinal enterocytes are responsible for processing the hydrolysis products of dietary lipids. Intestinal absorption of lipids is highly efficient, with greater than 95% of dietary lipid taken up [17]. It is generally thought that the presence of lipid-binding proteins is critical for this capacity, particularly because levels of FABPs are very high in cytosol [3]. In the intestinal enterocyte, two FABPs are present, largely in the absorptive intestinal villus cells, but not in crypt

Liver fatty acid-binding protein

LFABP is a highly abundant intracellular protein in the intestinal enterocyte. It is present throughout the intestine, but is most highly expressed in the duodenum and jejunum [29]. In vitro studies have shown that LFABP binds FA with high affinity, with Kd values in the nanomolar range [30], [31]. LFABP is also unique among the FABPs in that it has two FA-binding sites, and thus has a higher binding capacity than other FABPs. It has also been shown to bind to other lipid species, including

Intestinal fatty acid-binding protein

Unlike LFABP, IFABP is solely expressed in intestinal enterocytes of mammals. While IFABP is present throughout the small intestine, its highest expression is in the jejunum [56]. Like LFABP, IFABP is found widely distributed throughout the cytosol of the enterocyte during the fed state, but is localized toward the apical side of the cell in the fasted state [34]. IFABP has not been found to be involved with chylomicron formation [35], [57]; hence, IFABP has been proposed to be involved with

LFABP and IFABP in intestinal lipid metabolism

It is unusual that one cell type expresses proteins with identical functions; therefore, it is generally believed that LFABP and IFABP have different roles in intestinal lipid metabolism. In the intestine, the hydrolytic products of dietary lipids from the lumen enter the enterocyte from the lumen across the apical side of the cell, while endogenous lipids present in the bloodstream are delivered across the basolateral side [71]. The entry site into the enterocyte markedly impacts the metabolic

LFABP−/− mice

Two laboratories have independently generated individual lines of whole body LFABP-null mice on the C57BL/6 background [61], [82]. Martin et al. published their first report on the LFABP−/− mouse in 2003, in which there was complete deletion of all four exons of the LFABP gene along with the promoter region. These mice were backcrossed six times to the C57BL/6N mouse strain [82]. Newberry et al. also published a report in 2003 in which green fluorescent protein was “knocked in” to exons 1 and 2

IFABP−/− mice

One line of IFABP−/− mice has been generated, which were backcrossed for six generations onto the C57BL/6J background by Vassileva et al. [62]. Male mice fed diets with 35 kcal% fat as coconut oil and 1.25% cholesterol had an increase in body weight relative to WT mice, and also developed fatty livers. By contrast, female mice gained less weight than WT and did not exhibit any changes in hepatic lipid accumulation [62]. It was further found that aged (30- to 40-week old) male IFABP−/− mice fed 41

Direct comparison between LFABP−/− and IFABP−/− mice

To further investigate and systematically address the individual functions of these proteins, Lagakos et al. conducted comparative studies using both LFABP- and IFABP-null mice. LFABP-null mice, which were initially generated by Martin et al. [82], were used. These mice, which as noted above had been backcrossed for six generations onto the C57BL/6N strain, were backcrossed for another six generations onto the C57BL/6J strain [44]. IFABP−/− mice were bred from those used originally by Vassileva

Summary and perspective

Perhaps surprisingly, deletion of either LFABP or IFABP does not result in dietary lipid malabsorption, even with chronic high-fat feeding. Furthermore, and more remarkably, preliminary studies of an LFABP/IFABP double-knockout mouse show no increase in fecal fat on a high-fat diet (AM Gajda and J Storch, unpublished results). Ablation of each of these genes results in changes in intestinal lipid metabolism, as shown schematically in Fig. 2. These changes, which are relatively modest,

References (99)

  • A.W. Zimmerman et al.

    Ligand specificity and conformational stability of human fatty acid-binding proteins

    Int. J. Biochem. Cell Biol.

    (2001)
  • J. Grober

    Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the Farnesoid X receptor/9-cis-retinoic acid receptor heterodimer

    J. Biol. Chem.

    (1999)
  • S.T. Hwang et al.

    Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor

    Gastroenterology

    (2002)
  • G. V Richieri et al.

    Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB

    J. Biol. Chem.

    (1994)
  • K.T. Hsu et al.

    Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms

    J. Biol. Chem.

    (1996)
  • D.H. Alpers et al.

    Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine

    Biochim. Biophys. Acta

    (2000)
  • S. Siddiqi et al.

    A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER

    J. Lipid Res.

    (2010)
  • M.T. Nakamura et al.

    Regulation of energy metabolism by long-chain fatty acids

    Prog. Lipid Res.

    (2014)
  • A.L. McIntosh et al.

    Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes

    Arch. Biochem. Biophys.

    (2009)
  • H.A. Hostetler et al.

    L-FABP directly interacts with PPARalpha in cultured primary hepatocytes

    J. Lipid Res.

    (2009)
  • A.L. McIntosh et al.

    Liver-type fatty acid binding protein interacts with hepatocyte nuclear factor 4α

    FEBS Lett.

    (2013)
  • A.M. Gajda et al.

    Direct comparison of mice null for liver- or intestinal fatty acid binding proteins reveals highly divergent phenotypic responses to high-fat feeding

    J. Biol. Chem.

    (2013)
  • P. Besnard et al.

    Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate

    FEBS Lett.

    (1993)
  • V. Petit et al.

    Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse

    J. Lipid Res.

    (2007)
  • J. Robitaille et al.

    Plasma concentrations of apolipoprotein B are modulated by a gene--diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men

    Mol. Genet. Metab.

    (2004)
  • E. Fisher et al.

    L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women

    Mol. Genet. Metab.

    (2007)
  • J.C. Sacchettini et al.

    Developmental and structural studies of an intracellular lipid binding protein expressed in the ileal epithelium

    J. Biol. Chem.

    (1990)
  • I. Neeli et al.

    Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum

    J. Biol. Chem.

    (2007)
  • J.B. Lowe et al.

    Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein

    J. Biol. Chem.

    (1987)
  • G. Halldén et al.

    Evidence for a role of the gut hormone PYY in the regulation of intestinal fatty acid-binding protein transcripts in differentiated subpopulations of intestinal epithelial cell hybrids

    J. Biol. Chem.

    (1997)
  • E.P. Newberry et al.

    Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene

    J. Biol. Chem.

    (2003)
  • R.E. Pratley et al.

    Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans

    J. Lipid Res.

    (2000)
  • L.J. Baier et al.

    A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells

    J. Biol. Chem.

    (1996)
  • E. Levy et al.

    The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants

    J. Biol. Chem.

    (2001)
  • J. Storch et al.

    Metabolism of apical versus basolateral sn-2-monoacylglycerol and fatty acids in rodent small intestine

    J. Lipid Res.

    (2008)
  • B.P. Atshaves et al.

    Liver fatty acid-binding protein and obesity

    J. Nutr. Biochem.

    (2010)
  • J.H. Veerkamp et al.

    Structural and functional aspects of cytosolic fatty acid-binding proteins, Prostaglandins

    Leukot. Essent. Fat. Acids

    (1993)
  • L.L. Listenberger et al.

    Palmitate-induced apoptosis can occur through a ceramide-independent pathway

    J. Biol. Chem.

    (2001)
  • G.G. Martin et al.

    Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene

    J. Biol. Chem.

    (2003)
  • G.G. Martin et al.

    Liver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity

    J. Nutr.

    (2008)
  • E.P. Newberry et al.

    Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice

    J. Lipid Res.

    (2012)
  • M.A. Williams et al.

    Hydrogenated coconut oil and tissue fatty acids in EFA-depleted and EFA-supplemented rats

    J. Nutr.

    (1972)
  • I. Niot et al.

    Intestinal absorption of long-chain fatty acids: Evidence and uncertainties

    Prog. Lipid Res.

    (2009)
  • R.K. Ockner et al.

    Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport

    J. Clin. Invest.

    (1974)
  • J. Storch et al.

    The emerging functions and mechanisms of mammalian fatty acid-binding proteins

    Annu. Rev. Nutr.

    (2008)
  • A.V. Hertzel et al.

    The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function

    Trends Endocrinol. Metab.

    (2000)
  • B. Córsico et al.

    The alpha-helical domain of liver fatty acid binding protein is responsible for the diffusion-mediated transfer of fatty acids to phospholipid membranes

    Biochemistry

    (2004)
  • B. Corsico et al.

    The helical domain of intestinal fatty acid binding protein is critical for collisional transfer of fatty acids to phospholipid membranes

    Proc. Natl. Acad. Sci. U. S. A

    (1998)
  • A. Chmurzyńska

    The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism

    J. Appl. Genet

    (2006)
  • Cited by (124)

    • Electroacupuncture promoted intestinal defensins and rescued the dysbiotic cecal microbiota of high-fat diet-induced obese mice

      2022, Life Sciences
      Citation Excerpt :

      CD36 plays an important role in intestinal lipid uptake and absorption, and CD36-deficient mice display insufficient functions in lipid uptake, assembly and secretion of celiac grains [44]. Fabp1 is a fatty acid-binding protein that responds to the uptake and transport of intestinal lipids [45]. In addition, the OFTT results showed that EA delayed lipid uptake in obese mice.

    • Elevated plasma intestinal fatty acid binding protein and aberrant lipid metabolism predict post-stroke depression

      2022, Heliyon
      Citation Excerpt :

      Lp(a), ApoB, TC, Apo A1, HDL-C, and LDL-C levels were significantly changed in PSD patients. On the one hand, iFABP has long been thought to be involved in the uptake and transport of dietary fatty acids (FAs) in the small intestine (Gajda and Storch, 2015). IFABP can bind more FAs after apical absorption and transport them for TG synthesis and chylomicron formation.

    View all citing articles on Scopus

    This work was supported, in whole or in part, by the National Institutes of Health Grant DK-38389 from NIDDK. This work was also supported by funds from the New Jersey Agricultural Experiment Station.

    View full text